PharmGKB summary: oxycodone pathway, pharmacokinetics
- PMID: 30222708
- PMCID: PMC6602093
- DOI: 10.1097/FPC.0000000000000351
PharmGKB summary: oxycodone pathway, pharmacokinetics
Conflict of interest statement
Conflict of interest: RBA is a stockholder in Personalis Inc. and 23andMe, and a paid advisor for Karius
Figures

Similar articles
-
[Interindividual variation of pharmacokinetic disposition of and clinical responses to opioid analgesics in cancer pain patients].Yakugaku Zasshi. 2015;135(5):709-15. doi: 10.1248/yakushi.14-00234-4. Yakugaku Zasshi. 2015. PMID: 25948306 Review. Japanese.
-
The pharmacokinetics of oxycodone.J Pain Palliat Care Pharmacother. 2004;18(4):17-30. doi: 10.1300/j354v18n04_03. J Pain Palliat Care Pharmacother. 2004. PMID: 15760805 Review.
-
Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.Pain Med. 2014 May;15(5):723-5. doi: 10.1111/pme.12417. Epub 2014 Mar 17. Pain Med. 2014. PMID: 24636013 No abstract available.
-
Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.Clin Exp Pharmacol Physiol. 2008 Mar;35(3):295-302. doi: 10.1111/j.1440-1681.2007.04821.x. Epub 2007 Oct 31. Clin Exp Pharmacol Physiol. 2008. PMID: 17973932
-
Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.Pain Med. 2014 May;15(5):791-806. doi: 10.1111/pme.12380. Epub 2014 Feb 12. Pain Med. 2014. PMID: 24517173 Clinical Trial.
Cited by
-
Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone Reward.J Pharmacol Exp Ther. 2022 Aug;382(2):167-180. doi: 10.1124/jpet.122.001217. Epub 2022 Jun 10. J Pharmacol Exp Ther. 2022. PMID: 35688478 Free PMC article.
-
Hydrocodone, Oxycodone, and Morphine Metabolism and Drug-Drug Interactions.J Pharmacol Exp Ther. 2023 Nov;387(2):150-169. doi: 10.1124/jpet.123.001651. Epub 2023 Sep 7. J Pharmacol Exp Ther. 2023. PMID: 37679047 Free PMC article. Review.
-
Opioid Drug-Drug-Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three-Way Drug Interaction Signals.Front Pharmacol. 2022 May 10;13:845485. doi: 10.3389/fphar.2022.845485. eCollection 2022. Front Pharmacol. 2022. PMID: 35620282 Free PMC article.
-
Importance of cytochrome 3A4 and 2D6-mediated drug-drug interactions in oxycodone consumption among older adults hospitalized for hip fracture: a cross-sectional study.Aging Clin Exp Res. 2023 Nov;35(11):2471-2481. doi: 10.1007/s40520-023-02569-7. Epub 2023 Oct 20. Aging Clin Exp Res. 2023. PMID: 37861957
-
The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice.Pharmaceutics. 2023 Apr 6;15(4):1165. doi: 10.3390/pharmaceutics15041165. Pharmaceutics. 2023. PMID: 37111650 Free PMC article. Review.
References
-
- Olkkola KT, et al., Does the pharmacology of oxycodone justify its increasing use as an analgesic? Trends Pharmacol Sci, 2013. 34(4): p. 206–14. - PubMed
-
- Falk E, Eukodal, ein neues Narkotikum. Munchener Medizinische Wochenschrift, 1917. 20: p. 381–384.
-
- Riley J, et al., Oxycodone: a review of its use in the management of pain. Curr Med Res Opin, 2008. 24(1): p. 175–92. - PubMed
-
- Poyhia R and Seppala T, Liposolubility and protein binding of oxycodone in vitro. Pharmacol Toxicol, 1994. 74(1): p. 23–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources